NVLN* nears formal dissolution: https://www.globenewswire.com/news-release/2020/01/03/1966000/0/en/Novelion-Therapeutics-Provides-Updates-on-Voluntary-Liquidation-and-Other-Matters.html NVLN is the result of the 2016 QLTI-AEGR merger (#msg-123312384). *The current Nasdaq ticker is NVLNF.